InsidersTradesSigma
Total declarations
Company
▲ Purchases (17 ops.)
▼ Sales (0 ops.)
Insider track record
OtherDisclosed buys
17
Disclosed sells
0
T+90 hit rate
0%
T+90 mean return
-47.4%
Across 14 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Browse the detailed record of transactions filed by Thrive Partners VII Growth GP, LLC. Director active across 1 company, notably Oscar Health, Inc.. Cumulatively, 17 reports have been published. Split: 17 buys · 0 sell. Total volume traded: €47.7m. History available since 20 August 2021. The latest transaction was filed on 20 November 2024 (Acquisition). Regulator: SEC (Form 4). All data is openly available.
Declarations17 total
88,395 shares@ US$16.96593.0% of flowClass A Common StockSEC:0000950170-24-130257:0
Ideal exit: 17 Aug 2025 (T+270)
158,732 shares@ US$15.61244.9% of flowClass A Common StockSEC:0000950170-24-128068:0
Ideal exit: 11 Aug 2025 (T+270)
276,040 shares@ US$13.57797.3% of flowClass A Common StockSEC:0000950170-24-126662:0
Ideal exit: 8 Aug 2025 (T+270)
180,891 shares@ US$17.23180.037% mcap6.5% of flowClass A Common StockSEC:0000899243-21-038101:0
Ideal exit: 6 Jun 2022 (T+270)
180,891 shares@ US$17.23185.5% of flowClass A Common StockSEC:0000899243-21-038101
Ideal exit: 6 Jun 2022 (T+270)
515,344 shares@ US$18.0970.11% mcap19.5% of flowClass A Common StockSEC:0000899243-21-036299:0
Ideal exit: 11 Jun 2022 (T+270)
515,344 shares@ US$18.09716.6% of flowClass A Common StockSEC:0000899243-21-036299
Ideal exit: 11 Jun 2022 (T+270)
180,891 shares@ US$17.23185.5% of flowClass A Common StockSEC:0000899243-21-035729
Ideal exit: 6 Jun 2022 (T+270)
180,891 shares@ US$17.23180.037% mcap6.5% of flowClass A Common StockSEC:0000899243-21-035729:0
Ideal exit: 6 Jun 2022 (T+270)
167,966 shares@ US$17.52620.035% mcap6.1% of flowClass A Common StockSEC:0000899243-21-035248:0
Ideal exit: 30 May 2022 (T+270)
167,966 shares@ US$17.52625.2% of flowClass A Common StockSEC:0000899243-21-035248
Ideal exit: 30 May 2022 (T+270)
274,697 shares@ US$14.68440.049% mcap8.5% of flowClass A Common StockSEC:0000899243-21-034820:0
Ideal exit: 27 May 2022 (T+270)
274,697 shares@ US$14.68447.2% of flowClass A Common StockSEC:0000899243-21-034820
Ideal exit: 27 May 2022 (T+270)
31,794 shares@ US$13.17570.0051% mcap0.9% of flowClass A Common StockSEC:0000899243-21-034460:0
Ideal exit: 22 May 2022 (T+270)
31,794 shares@ US$13.17570.7% of flowClass A Common StockSEC:0000899243-21-034460
Ideal exit: 22 May 2022 (T+270)
68,042 shares@ US$13.41220.011% mcap1.9% of flowClass A Common StockSEC:0000899243-21-034081:0
Ideal exit: 17 May 2022 (T+270)
68,042 shares@ US$13.41221.6% of flowClass A Common StockSEC:0000899243-21-034081
Ideal exit: 17 May 2022 (T+270)
17 of 17 declarations
About Thrive Partners VII Growth GP, LLC
Thrive Partners VII Growth GP, LLC is a director and insider at Oscar Health, Inc.
